ICD-10 Coding for Infusion of Immunoglobulins(D69.3, D69.3B, D69.3I)
Learn about ICD-10 coding for immunoglobulin infusion procedures, including primary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Infusion of Immunoglobulins
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D80.0 | Hereditary hypogammaglobulinemia | Use for confirmed hereditary hypogammaglobulinemia with documented low IgG levels. |
|
| G61.81 | Chronic inflammatory demyelinating polyneuritis | Use for CIDP with documented clinical and electrodiagnostic evidence. |
|
| D69.3 | Immune thrombocytopenic purpura | Use for chronic ITP with documented low platelet count and treatment resistance. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutInfusion of Immunoglobulins
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Infusion of Immunoglobulins.
Vague documentation of immune deficiency
Impact
Clinical: Inadequate treatment justification, Regulatory: Non-compliance with documentation standards, Financial: Potential claim denials
Mitigation
Use specific ICD-10 codes, Include detailed clinical evidence
Incorrect sequencing of codes
Impact
Reimbursement: Denial of claims, Compliance: Non-compliance with coding guidelines, Data Quality: Inaccurate clinical data representation
Mitigation
Always sequence the underlying condition before the procedure code.
Using incorrect J codes for IG products
Impact
Reimbursement: Potential claim denials, Compliance: Incorrect billing, Data Quality: Misleading treatment records
Mitigation
Verify the specific IG product and administration route before coding.
Incorrect use of J codes
Impact
Using incorrect J codes for different immunoglobulin products.
Mitigation
Verify product and administration route before coding.